Immusoft Corp. is based in Seattle, Washington, and operates as a corporate entity engaged in technical research and business operations.
Subscribe to see Immusoft Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Immusoft Corp is a drug discovery company headquartered in United States. Its most recent funding round raised $4.6M in May 2024. Xcout tracks 9 named people at Immusoft Corp, including Sean Ainsworth (Chief Executive Officer and Chairman of the Board).
3 more named people on record for Immusoft Corp, with roles, board committees and tenure — see the full roster →
The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $4.6M | — | |
| SEC Form D filing | $10.3M | — | |
| — | $20M | 6 named | |
| SEC Form D filing | $3.6M | — | |
| Series B | $20.2M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.